ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Correction to Advanced Cancer Immunotherapy via SMARCAL1 Blockade Using a Glucose-Responsive CRISPR Nanovaccine.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.